secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAPTYSBIO, INC (ANAB)
CIK:        0001370053
Form:       8-K
Filed at:   2026-08-11T20:05:17+00:00
Accession:  0001193125-26-344583
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AnaptysBio annual meeting: directors elected, KPMG ratified, equity plan amended
--------------------------------------------------------------------------------

- Stockholders elected Hollings Renton (15,304,522 for) and John P. Schmid (20,314,669 for) as Class III directors for 3-year terms.
- Ratified KPMG LLP as independent auditor for fiscal year ending June 30, 2027: 22,343,352 votes for.
- Advisory say-on-pay approved: 21,274,791 votes for; 609,979 against.
- Approved amendment to 2017 Equity Incentive Plan extending term 10 years from Aug 11, 2026 and capping non-employee director comp at $1M (first year) / $750K (subsequent years).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1370053/000119312526344583/0001193125-26-344583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1370053/000119312526344583/anab-20260811.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-344583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer